gdc

Gastric Cancer

Opdivo First Immunotherapy Approved for First-Line Therapy of Gastric Cancers
FDA Approvals, News & UpdatesGastric CancerImmunotherapy
In April 2021, the FDA approved Opdivo (nivolumab), for use with chemotherapy, as first-line treatment for patients with advanced or metastatic gastric cancer, including gastroesophageal junction cancer and esophageal adenocarcinoma.
Keytruda Another Immunotherapy Approved for First-Line Treatment of Advanced Gastric Cancer
FDA Approvals, News & UpdatesGastric CancerImmunotherapy
In May 2021, the FDA approved Keytruda (pembrolizumab), plus Herceptin and chemotherapy, for first-line treatment of locally advanced unresectable or metastatic, HER2-positive gastric or gastroesophageal junction adenocarcinoma. Keytruda is the second immunotherapy approved for gastric cancer.
Why a Healthy Diet Is So Important for Patients with Gastric Cancer
Nutrition & CancerGastric Cancer
“Because gastric cancers involve the digestive system, following a healthy diet is especially important for patients with this type of cancer,” says Martha Raymond, Founding Executive Director of the GI Cancers Alliance.
Drugs for GIST (Gastrointestinal Stromal Tumor)
Gastric Cancer
Here are the drugs and financial support services available to patients receiving treatment for GIST (Gastrointestinal Stromal Tumor).
Drugs for Gastric/Gastroesophageal Junction Cancer
Gastric Cancer
Here are the drugs and financial support services available to patients receiving treatment for Gastric/Gastroesophageal Junction Cancer.
Lonsurf Approved for Metastatic Gastric or Gastroesophageal Junction Cancer
FDA Approvals, News & UpdatesGastric Cancer
In February 2019, the FDA approved Lonsurf for the treatment of patients with metastatic gastric (stomach) cancer or gastroesophageal junction adenocarcinoma. This drug was previously approved only for patients with metastatic colorectal cancer.
A Disney Childhood Until Cancer Enters Stage Left
Gastric CancerPatient Stories
Cathy Sherman Freeman’s father, who was Head of Publications at Walt Disney Studios, passed away of gastrointestinal stromal tumor (GIST), the same rare cancer she was diagnosed with several years ago.

Results 1 - 8 of 8

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest